Literature DB >> 8698475

Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis.

S A Fulton1, J M Johnsen, S F Wolf, D S Sieburth, W H Boom.   

Abstract

Mycobacterium tuberculosis and its antigens are potent inducers of cytokine expression by mononuclear phagocytes. In this study, the ability of live M. tuberculosis to stimulate interleukin-12 (IL-12) expression by human monocytes was examined. Monocytes were purified from peripheral blood mononuclear cells by adherence and either infected with M. tuberculosis or exposed to soluble protein antigens of M. tuberculosis (purified protein derivative [PPD]). Live M. tuberculosis (10(6) to 10(7) CFU/ml) was a potent stimulus for interleukin-12 (IL-12). By using reverse transcription-PCR, p40 mRNA was detected at 3 h, peaked at 6 to 12 h, and decayed to baseline levels at 18 to 24 h following infection. Bioactive IL-12 (p70) was measured by the phytohemagglutinin blast proliferation assay and confirmed the p40 mRNA results. In contrast, soluble PPD at concentrations known to readily induce IL-1 and tumor necrosis factor alpha expression by monocytes (10 to 100 microg/ml) was a poor stimulus for IL-12 p40 mRNA expression. The different efficiencies of M. tuberculosis bacilli and PPD for IL-12 expression by monocytes was in part due to a requirement for phagocytosis. Induction of IL-12 in response to M. tuberculosis was reduced by cytochalasin D. Furthermore, phagocytosis of dead M. tuberculosis or inert 2-micron-diameter polystyrene beads by monocytes induced IL-12 p40 mRNA. In contrast, 0.5-micron-diameter beads, which can enter cells through pinocytosis, did not stimulate IL-12 expression. Functionally, IL-12 readily enhanced PPD-stimulated IFN-gamma production and CD4+ T-cell-mediated cytotoxicity by peripheral blood mononuclear cells from healthy tuberculin-positive donors but induced less enhancement when live M. tuberculosis was the antigen. These results suggest that IL-12 is upregulated as part of the early cytokine response of mononuclear phagocytes to M. tuberculosis and that the cellular events associated with phagocytosis are themselves a potent signal for IL-12 production. IL-12 released by infected macrophages in turn can further upregulate M. tuberculosis-specific CD4+ T-cell effector function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698475      PMCID: PMC174106          DOI: 10.1128/iai.64.7.2523-2531.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

1.  Removal of gram-negative endotoxin from solutions by affinity chromatography.

Authors:  A C Issekutz
Journal:  J Immunol Methods       Date:  1983-07-29       Impact factor: 2.303

2.  Epidemiology of tuberculosis.

Authors:  G W Comstock
Journal:  Am Rev Respir Dis       Date:  1982-03

3.  IL-12 regulates T helper type 1 cytokine responses in human infectious disease.

Authors:  P A Sieling; X H Wang; M K Gately; J L Oliveros; T McHugh; P F Barnes; S F Wolf; L Golkar; M Yamamura; Y Yogi; K Uyemura; T H Rea; R L Modlin
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

4.  Cell membrane antigen isolation with the staphylococcal protein A-antibody adsorbent.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

5.  Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

Authors:  C L Nastala; H D Edington; T G McKinney; H Tahara; M A Nalesnik; M J Brunda; M K Gately; S F Wolf; R D Schreiber; W J Storkus
Journal:  J Immunol       Date:  1994-08-15       Impact factor: 5.422

6.  IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni.

Authors:  I P Oswald; P Caspar; D Jankovic; T A Wynn; E J Pearce; A Sher
Journal:  J Immunol       Date:  1994-08-15       Impact factor: 5.422

7.  Interleukin 12 at the site of disease in tuberculosis.

Authors:  M Zhang; M K Gately; E Wang; J Gong; S F Wolf; S Lu; R L Modlin; P F Barnes
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

8.  Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma.

Authors:  C S Tripp; M K Gately; J Hakimi; P Ling; E R Unanue
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

9.  B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation.

Authors:  E E Murphy; G Terres; S E Macatonia; C S Hsieh; J Mattson; L Lanier; M Wysocka; G Trinchieri; K Murphy; A O'Garra
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

10.  Role of phagocytosis in the activation of macrophages.

Authors:  J Schnyder; M Baggiolini
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  45 in total

1.  Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy.

Authors:  Hans Grönlund; Susanne Vrtala; Ursula Wiedermann; Gerhard Dekan; Dietrich Kraft; Rudolf Valenta; Marianne Van Hage-Hamsten
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins.

Authors:  L Pitzurra; R Cherniak; M Giammarioli; S Perito; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta.

Authors:  C Manca; L Tsenova; A Bergtold; S Freeman; M Tovey; J M Musser; C E Barry; V H Freedman; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

4.  Comparison of the Effect of Ribosomal Immunotherapy on Plasma Levels of Total IgE and Cytokines IL-4, IL-5, IL-12 and IFNgamma in Adult Atopic and Non-Atopic Patients during the Pollen Season.

Authors:  J Bystron; Z Hermanová; J Szotkovská; L Heller; D Pazderová
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

5.  Effect of Ribosomal Immunotherapy on the Clinical Condition and Plasma Levels of Cytokines IL-4, IL-5, IL-12 and IFNgamma and Total IgE in Patients with Seasonal Allergy during the Pollen Season.

Authors:  J Bystron; Z Hermanová; J Szotkovská; L Heller; D Pazderová
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

6.  In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis.

Authors:  V Hari Sai Priya; B Anuradha; Suman Latha Gaddam; Seyed E Hasnain; K J R Murthy; Vijaya Lakshmi Valluri
Journal:  Clin Vaccine Immunol       Date:  2008-11-05

7.  Interleukin-12 gene expression in human monocyte-derived macrophages stimulated with Mycobacterium bovis BCG: cytokine regulation and effect of NK cells.

Authors:  H Matsumoto; K Suzuki; K Tsuyuguchi; E Tanaka; R Amitani; A Maeda; K Yamamoto; M Sasada; F Kuze
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

8.  Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis.

Authors:  Y Lin; M Zhang; P F Barnes
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

9.  Inhibition of monocytic interleukin-12 production by Candida albicans via selective activation of ERK mitogen-activated protein kinase.

Authors:  Ningfeng Tang; Liming Liu; Kefei Kang; Pranab K Mukherjee; Masakazu Takahara; Guofen Chen; Thomas S McCormick; Kevin D Cooper; Mahmoud Ghannoum
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Human alveolar macrophage gene responses to Mycobacterium tuberculosis strains H37Ra and H37Rv.

Authors:  Richard F Silver; Jessica Walrath; Hung Lee; Bruce A Jacobson; Heidi Horton; Michael R Bowman; Karl Nocka; Joseph P Sypek
Journal:  Am J Respir Cell Mol Biol       Date:  2008-09-11       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.